AI, blockchain, Big Data:

how new technologies can change patients life

These are the topics of Wired Health 2019, held on March 13, in Milan. International players such as Viktor Savevski, Chief Digital Officer of Humanitas, John Nosta, president of NostaLab, Jaquie Finn, Head of digital health of Cambridge Consultants, Ismene Grohmann, Senior director innovation Diabetes care of Abbot. Realities such as the University La Sapienza di Roma, Pfizer, Samsung, the Italian Institute of Tencology, Takeda, and politicians like Giulia Grillo, Health Minister, have spoken during the day.

Our experience

JSB talked about blockchain with Massimiliano Barawitzka, Healthcare communication expert and Cysed Shareholding partner, during the Heath Tech session – “When blockchain is needed”. Jacopo Montigiani explained what is blockchain: “Blockchain is a technology that enables the asset management, that started with Bitcoin to then manage any type of property, enabling a secure exchange of information”.

The focus moved to the pharmaceutical field, talking about blockchain application to supply chain, logistics, clinical area and how this technology can manage transactions in a safer way. Blockchain would become a warranty for transparency, security and data integrity.

But what are the beneficiaries of this technology? “If the patient will have mainly indirect benefits, the companies and the regulatory agencies will have a huge impact given by the security guaranteed by blockchain. Just think of the impact it will have on the problem of counterfeit drugs”, said Jacopo Montigiani.

The obstacles to change

Max Barawitzka explained what are the main barriers to blockchain application. There are many regulatory barriers: “a regulatory framework is needed. In Europe, something is already moving ahead, and even Italy is taking its first steps “. It is also diffucult make the system understand the benefits of this technology: patients, companies and regulatory agency needs to know the advantages of blockchain.

In addition, there is a lack of know-how, especially in Italy, that could be an obstacle. It is fundamental that all the players make an act of courage and trust, welcoming young university researchers, making their processes available for real, strong and courageous experiments.

It seems clear that something is already changing, both companies and public bodies have begun to focus their attention on the application of these new technologies. Moving forward starting from a political will, could increase trust in the system and be a further reason for change.